Clinical Trial Detail

NCT ID NCT01366144
Title Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

ureter cancer

lung cancer

breast cancer

Advanced Solid Tumor

bladder carcinoma

ureter transitional cell carcinoma

endometrial cancer

testicular lymphoma

urethra cancer

ovarian cancer

melanoma

renal pelvis transitional cell carcinoma

esophageal cancer

Therapies

Paclitaxel

Veliparib

Carboplatin

Age Groups: senior adult

No variant requirements are available.